If you find yourself in front of an examiner with a high allowance rate, first, breathe a sigh of relief. Then, consider the next steps in your prosecution strategy. 

When it comes to patent prosecution, knowing your examiner’s allowance rate can give you a great insight into the road that lies ahead. 

Juristat’s normalized allowance rate factors in both average examiner allowance rate and the USPTO average allowance rate to provide a more specific metric to evaluate your patent prosecution strategy.

If you knew your assigned USPTO examiner was going to procrastinate on your application, how would it impact your prosecution strategy?

By strategically leveraging 102 Forward Cite Reports, you can increase your value by acting as an advisor, not just an attorney. 

The Mayo/Myriad standard arguably introduced a great deal of uncertainty into the feasibility of obtaining patent protection for life sciences innovations and has been accused of curtailing the competitiveness of U.S.-based life sciences companies in the global marketplace.

When it comes to office actions and your patent prosecution strategy, less is definitely more. Less time, less work, more profit, and more satisfied clients. Based on Juristat’s recent ranking though, some USPTO examiners might be thinking more is more. 

Knowing which examiners issue the most OAs per application on average can help you find the most efficient path to approval for your client.

Finding an IP firm with experience claiming foreign priority is critical for companies based in or working in foreign markets. Here, we rank the top firms for foreign priority applications, based on volume.

To craft an unbeatable prosecution strategy, patent attorneys should rely on the multi-dimensional analysis of an examiner’s data, rather than just summary metrics.

There are two types of patent petitions: petitions that are so routine you can do them in your sleep and those so rare you don’t even know where to start. Here are the most and least common petitions filed at the USPTO.